AU2003280324A1 - Pharmaceutical allergen product - Google Patents

Pharmaceutical allergen product

Info

Publication number
AU2003280324A1
AU2003280324A1 AU2003280324A AU2003280324A AU2003280324A1 AU 2003280324 A1 AU2003280324 A1 AU 2003280324A1 AU 2003280324 A AU2003280324 A AU 2003280324A AU 2003280324 A AU2003280324 A AU 2003280324A AU 2003280324 A1 AU2003280324 A1 AU 2003280324A1
Authority
AU
Australia
Prior art keywords
allergen product
pharmaceutical
pharmaceutical allergen
product
allergen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280324A
Inventor
Stig Aasmul-Olsen
Jan Sondergaard Andersen
Christian Gauguin Houghton
Henrik Hugo Jacobi
Annette Rommelmayer Lundegaard
Lise Lund Maerkedahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALK Abello AS filed Critical ALK Abello AS
Publication of AU2003280324A1 publication Critical patent/AU2003280324A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
    • B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Composite Materials (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
AU2003280324A 2002-11-26 2003-11-14 Pharmaceutical allergen product Abandoned AU2003280324A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US42908602P 2002-11-26 2002-11-26
DKPA200201825 2002-11-26
USUS60/429,086 2002-11-26
DKPA200201825 2002-11-26
DKPA200300279 2003-02-24
DKPA200300279 2003-02-24
PCT/DK2003/000784 WO2004047793A1 (en) 2002-11-26 2003-11-14 Pharmaceutical allergen product

Publications (1)

Publication Number Publication Date
AU2003280324A1 true AU2003280324A1 (en) 2004-06-18

Family

ID=32397517

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2003280324A Abandoned AU2003280324A1 (en) 2002-11-26 2003-11-14 Pharmaceutical allergen product
AU2003283207A Expired AU2003283207C1 (en) 2002-11-26 2003-11-26 An allergen dosage form
AU2010200798A Expired AU2010200798B2 (en) 2002-11-26 2010-03-03 An allergen dosage form

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2003283207A Expired AU2003283207C1 (en) 2002-11-26 2003-11-26 An allergen dosage form
AU2010200798A Expired AU2010200798B2 (en) 2002-11-26 2010-03-03 An allergen dosage form

Country Status (17)

Country Link
US (6) US20040166123A1 (en)
EP (2) EP2436395B1 (en)
JP (2) JP5442924B2 (en)
KR (2) KR20050103187A (en)
CN (1) CN101816787A (en)
AU (3) AU2003280324A1 (en)
BR (1) BR0316564A (en)
CA (1) CA2507551A1 (en)
CO (1) CO5690534A2 (en)
HK (1) HK1087008A1 (en)
IL (1) IL168733A (en)
IS (1) IS7894A (en)
MX (2) MXPA05005528A (en)
NO (1) NO20053142L (en)
NZ (1) NZ540850A (en)
PL (1) PL218350B1 (en)
WO (2) WO2004047793A1 (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020051794A1 (en) 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
US7927600B2 (en) * 2001-03-30 2011-04-19 Emile Loria Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8491909B2 (en) 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
ES2317313T3 (en) * 2004-10-19 2009-04-16 Krka, Tovarna Zdravil, D.D., Novo Mesto SOLID PHARMACEUTICAL COMPOSITION INCLUDING DONEPEZIL CHLORHYDRATE.
ATE468135T1 (en) * 2004-11-10 2010-06-15 Alk Abello As METHOD FOR THE PREVENTIVE TREATMENT OF ALLERGIES BY ADMINISTRATION OF AN ALLERGY VACCINE TO THE MUCOUS MEASURES
US20060210590A1 (en) * 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
CN103203016A (en) 2005-03-18 2013-07-17 赛托斯生物技术公司 Cat Allergen Fusion Proteins And Uses Thereof
US20090155351A1 (en) 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
EP1814516B1 (en) * 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
CN103933562A (en) * 2005-11-04 2014-07-23 爱尔开-阿贝优公司 Use of a liquid allergy vaccine formulation for oromucosal administration
CA2634507A1 (en) 2005-12-23 2007-06-28 Alk-Abello A/S Method for dissolution testing of pharmaceutical products
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
CN101678012A (en) * 2007-06-12 2010-03-24 阿尔克-阿贝洛有限公司 The allergen dosage form that comprises antihistaminic
GB0711683D0 (en) * 2007-06-16 2007-07-25 Enigma Diagnostics Ltd Compositions
ATE542540T1 (en) 2007-09-11 2012-02-15 Uinv Kobenhavns PREVENTION OF DIABETES BY ADMINISTRATION OF GLIADIN
DE202008006598U1 (en) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergy vaccine formulation for mucosal administration
WO2010086989A1 (en) 2009-01-29 2010-08-05 日東電工株式会社 Intraoral film-shaped base and preparation
JP5588688B2 (en) 2010-01-28 2014-09-10 日東電工株式会社 Film-form preparation
WO2011112788A1 (en) * 2010-03-12 2011-09-15 Antigen Laboratories, Inc. Methods of treating allergies with substantially phenol-free carriers
JP5751868B2 (en) 2010-03-30 2015-07-22 日東電工株式会社 Film-form preparation and method for producing the same
JP5800527B2 (en) * 2010-03-30 2015-10-28 日東電工株式会社 Stabilized pharmaceutical composition, stabilized pharmaceutical composition solution preparation, film-form preparation and method for producing film-form preparation
TR201906326T4 (en) * 2010-04-30 2019-05-21 Allovate Llc Toothpaste for allergic desensitization with oral mucosa.
WO2011137422A2 (en) * 2010-04-30 2011-11-03 Apellis Pharmaceuticals, Inc. Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
WO2011151449A1 (en) 2010-06-03 2011-12-08 Alk-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
AR083361A1 (en) 2010-10-08 2013-02-21 Scherer Technologies Inc R P FAST DOSAGE FORM ORAL VACCINE DISSOLUTION USING ALMIDON
JP5875246B2 (en) * 2010-12-10 2016-03-02 日東電工株式会社 Sheet-form preparation and method for producing sheet-form preparation
JP5555148B2 (en) * 2010-12-10 2014-07-23 日東電工株式会社 Sheet-form preparation and method for producing sheet-form preparation
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
FI20115374A0 (en) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy New hypoallergens
FI20115375A0 (en) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy New hypoallergens
US20120294894A1 (en) * 2011-05-20 2012-11-22 Nitto Denko Corporation Pharmaceutical composition and method for producing the same
JP5952634B2 (en) * 2011-05-20 2016-07-13 日東電工株式会社 Pharmaceutical composition and method for producing the same
JP5931449B2 (en) 2012-01-11 2016-06-08 日東電工株式会社 Pharmaceutical composition and method for producing the same
JP5841433B2 (en) 2012-01-11 2016-01-13 日東電工株式会社 Intraoral film-form base and preparation
MX2014009285A (en) * 2012-02-07 2015-02-04 Jolla Inst Allergy Immunolog Timothy grass allergens and methods and uses for immune response modulation.
WO2013173697A1 (en) * 2012-05-17 2013-11-21 The Johns Hopkins University Orally dissolving thin films containing allergens and methods of making and use
JP2014034530A (en) * 2012-08-07 2014-02-24 Nitto Denko Corp Allergen-containing sheet-like preparation and method of manufacturing the same
IN2015KN00414A (en) 2012-08-21 2015-07-17 Sanofi Sa
CN103215236A (en) * 2013-01-29 2013-07-24 中国科学院昆明动物研究所 Dust mite allergens Derf8 and Derf20, and genes and applications thereof
ES2503516B1 (en) * 2013-04-03 2015-09-09 Inmunotek, S.L. IMMUNOGENIC COMPLEX FOR VACCINATION AND METHOD OF OBTAINING
TWI633891B (en) 2013-06-04 2018-09-01 再生元醫藥公司 Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
KR102385900B1 (en) 2013-09-19 2022-04-11 알로베이트, 엘엘씨 Toothpaste for delivering allergens to oral mucosa
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
AU2015316552C1 (en) 2014-09-17 2018-08-23 Steerlife India Private Limited Effervescent composition and method of making it
IL294554B2 (en) 2014-11-14 2023-11-01 Regeneron Pharma Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
EP3506931A1 (en) 2016-09-01 2019-07-10 Regeneron Pharmaceuticals, Inc. Methods for preventing or treating allergy by administering an il-4r antagonist
US10359292B2 (en) 2017-04-05 2019-07-23 International Business Machines Corporation Deep learning allergen mapping
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
MA46269A (en) 2017-08-18 2019-07-31 Regeneron Pharma METHODS OF TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
US11034768B2 (en) 2017-10-30 2021-06-15 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy
AU2019310602A1 (en) 2018-07-27 2021-02-04 Societe Des Produits Nestle S.A. Oral immunotherapy unit dose dispensing systems and methods
EA202190544A1 (en) * 2018-08-16 2021-06-18 Биохэйвен Терапьютикс Лтд. APPLICATION OF RILUZOL TABLETS DISPOSING IN THE ORAL CAVITY FOR THE TREATMENT OF DISEASES
US20200054738A1 (en) * 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
CN113366301A (en) * 2018-11-30 2021-09-07 豪夫迈·罗氏有限公司 Laser-induced breakdown spectroscopy for determining contaminants in lyophilized drugs
BR112021018627A2 (en) 2019-03-21 2021-11-23 Regeneron Pharma Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for the treatment of allergy
JP2022532547A (en) 2019-05-10 2022-07-15 アイミューン セラピューティクス，インコーポレイテッド Ways to improve the quality of life of patients with peanut allergies
KR20220042217A (en) 2019-08-05 2022-04-04 리제너론 파아마슈티컬스, 인크. A method for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
JP7050734B2 (en) * 2019-09-30 2022-04-08 鳥居薬品株式会社 Film preparation for sublingual allergen immunotherapy
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278877A (en) * 1883-06-05 Ribbon or label holder for hats
US57856A (en) * 1866-09-11 Improvement in cultivators
US107208A (en) * 1870-09-06 Improvement in apparatus for the manufacture of illuminating-gas
US44351A (en) * 1864-09-20 Gang-plow
US346622A (en) * 1886-08-03 Bedstead
US271079A (en) * 1883-01-23 Grain weigher and tally
US2378383A (en) * 1942-10-17 1945-06-19 Brush Dev Co Transient signal recordingreproducing device
US3816314A (en) * 1972-05-31 1974-06-11 Exxon Research Engineering Co Block copolymers of unsaturated ester and a nitrogen containing monomer as v.i.improving and dispersant additives for oils
DD107208A1 (en) * 1973-06-04 1974-07-20
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4371513A (en) * 1977-03-25 1983-02-01 W. R. Grace & Co. Alumina compositions
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US4822611A (en) 1986-12-09 1989-04-18 Immunotec, Inc. Oral hyposensitization in the treatment of allergies
FR2609895B1 (en) 1987-01-28 1991-06-28 Bruttmann Georges NEW GALENIC FORMS OF ALLERGENS FOR PER- AND SUB-LINGUAL ADMINISTRATION
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
IT1217628B (en) * 1988-05-18 1990-03-30 Neo Abello Spa PHARMACEUTICAL FORM AND SUPPORT FOR THE ADMINISTRATION OF HELLERGENIC EXTRACTS
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
JPH0537070A (en) 1991-07-26 1993-02-12 Sharp Corp Manufacture of distributed feedback type semiconductor laser element
JPH0597672A (en) * 1991-10-08 1993-04-20 Terumo Corp Amide derivative-containing solid preparation and its production
AU3949093A (en) * 1992-03-31 1993-11-08 Benzon Pharma A/S A pharmaceutical formulation
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5343762A (en) 1992-10-05 1994-09-06 Rosemount Inc. Vortex flowmeter
US5343672A (en) * 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6074673A (en) 1996-04-22 2000-06-13 Guillen; Manuel Slow-release, self-absorbing, drug delivery system
JP2832885B2 (en) 1996-09-02 1998-12-09 株式会社林原生物化学研究所 Cedar pollen allergen
US7025964B1 (en) * 1996-11-13 2006-04-11 Meiji Dairies Corporation Peptide-based immunotherapeutic agent
DE69840495D1 (en) * 1997-02-20 2009-03-12 Massachusetts Inst Technology PHARMACEUTICAL FORM WHICH DELETES RAPID DISPERSION PROPERTIES, METHOD OF USE, AND METHOD FOR THE PRODUCTION THEREOF
DE19713001A1 (en) 1997-03-27 1998-10-01 Merck Patent Gmbh Gramina pollen allergen mutants for specific immunotherapy, their production and use
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
US20020197321A1 (en) * 1997-10-27 2002-12-26 Harry Seager Solid dispersing vaccine composition for oral delivery
PL194804B1 (en) 1998-03-16 2007-07-31 Alk Abello As Mutant recombinant allergens
GB9819484D0 (en) * 1998-09-07 1998-10-28 Univ Bristol Therapeutic agents
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
FR2790387B1 (en) 1999-03-01 2001-05-18 Prographarm Laboratoires ORODISPERSIBLE TABLET HAVING LOW FRIABILITY AND PROCESS FOR THE PREPARATION THEREOF
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (en) 1999-03-31 2003-05-09 Pf Medicament ISOTROPIC FAST DISSOLVING ISOTROPIC MICROPOROUS COMPOSITION OR STRUCTURE FOR PHARMACEUTICAL, VETERINARY, DIETETIC, FOOD OR COSMETIC USE AND PROCESS FOR OBTAINING THE SAME
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
SE9901857D0 (en) * 1999-05-21 1999-05-21 Anders Cedergren Karl Fischer reagent
US20010031262A1 (en) 1999-12-06 2001-10-18 Michael Caplan Controlled delivery of antigens
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
US6458968B2 (en) * 2000-06-09 2002-10-01 Rensselaer Polytechnic Institute Dithiocarboxylic ester synthetic process
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
ES2317955T3 (en) 2000-11-16 2009-05-01 Alk-Abello A/S MUTANT ALLERGENS.
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
GB2378383A (en) 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
DE10137232A1 (en) * 2001-07-30 2003-02-20 Pierre Foss Method for allergy testing and/or for sublingual immunotherapy, comprising placing marked allergen carrier with specified concentration and amount of allergen on mucous membrane or under tongue
CN1668737A (en) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 Recombined Bet-V-1 allergen mutants, its preparation method and equipment
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
DE202008006598U1 (en) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergy vaccine formulation for mucosal administration

Also Published As

Publication number Publication date
WO2004047794A2 (en) 2004-06-10
JP2011093926A (en) 2011-05-12
EP2436395A3 (en) 2012-06-20
US10471008B2 (en) 2019-11-12
EP2436395B1 (en) 2017-04-26
BR0316564A (en) 2005-10-04
IL168733A (en) 2011-01-31
MXPA05005527A (en) 2006-04-05
EP2436395A2 (en) 2012-04-04
JP5622594B2 (en) 2014-11-12
MXPA05005528A (en) 2006-04-05
US20170367970A1 (en) 2017-12-28
WO2004047793A1 (en) 2004-06-10
JP2006513269A (en) 2006-04-20
US20080187558A1 (en) 2008-08-07
AU2010200798B2 (en) 2012-11-15
NO20053142L (en) 2005-06-27
US20140271722A1 (en) 2014-09-18
AU2010200798A1 (en) 2010-03-25
KR101281147B1 (en) 2013-07-02
CA2507551A1 (en) 2004-06-10
AU2003283207C1 (en) 2010-07-29
CN101816787A (en) 2010-09-01
PL218350B1 (en) 2014-11-28
US20080193535A1 (en) 2008-08-14
PL377745A1 (en) 2006-02-20
KR20120034767A (en) 2012-04-12
AU2003283207A1 (en) 2004-06-18
NZ540850A (en) 2008-11-28
US8329196B2 (en) 2012-12-11
AU2003283207B2 (en) 2009-12-03
US20160324767A1 (en) 2016-11-10
IS7894A (en) 2005-06-14
KR20050103187A (en) 2005-10-27
WO2004047794A3 (en) 2004-09-16
CO5690534A2 (en) 2006-10-31
EP1567123A2 (en) 2005-08-31
US9415015B2 (en) 2016-08-16
US20040166123A1 (en) 2004-08-26
US9408805B2 (en) 2016-08-09
HK1087008A1 (en) 2006-10-06
US10080719B2 (en) 2018-09-25
JP5442924B2 (en) 2014-03-19

Similar Documents

Publication Publication Date Title
AU2003280324A1 (en) Pharmaceutical allergen product
GB0214013D0 (en) Pharmaceutical product
EP1615615A4 (en) Pharmaceutical products
AU2003221497A1 (en) Pharmaceutical microparticles
EP2289512B8 (en) Pharmaceutical foam
AU2003291103A1 (en) Pharmaceutical composition
ZA200509099B (en) Stabilized pharmaceutical product
AU2003235248A1 (en) Hyaluronic acid modification product
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003250372A1 (en) Pharmaceutical composition
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003226058A1 (en) Product dispenser
GB0315889D0 (en) Stable pharmaceutical products
AU2003244212A1 (en) Absorbable product
AU2003264406A1 (en) Drug or cosmetic
AU2003263897A1 (en) Medicinal product packaging
AUPS173302A0 (en) Three product cyclone
AU2003282700A1 (en) Kavalactone product
AU2003235236A1 (en) Lyophilization product
GB0201520D0 (en) Pharmaceutical uses
GB0316360D0 (en) Pharmaceutical product
AU2002343826A1 (en) Sanitary product
AU2003211940A1 (en) Drugs for mitochondrial diseases
AU2003238900A1 (en) Pharmaceutical formulation
AUPS188302A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase